Agenus Inc. (AGEN) is priced at $3.95 after the most recent trading session. At the very opening of the session, the stock price was $3.75 and reached a high price of $3.84, prior to closing the session it reached the value of $3.70. The stock touched a low price of $3.663.
Recently in News on December 1, 2020, Agenus Launches Phase 2 Trial Expansion in Colon Cancer for AGEN1181 in Combination with Balstilimab. New objective response in colon cancer triggers trial expansion. You can read further details here
Gold bugs are shouting from the rooftops in excitement, but that doesn’t mean you rush out and just buy any gold stock…That’s why we laid out The 2021 Ultimate Gold Portfolio – to dissect the treasure from the trash.
Agenus Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $5.63 on 09/11/20, with the lowest value was $1.82 for the same time period, recorded on 03/23/20.
Agenus Inc. (AGEN) full year performance was -11.69%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Agenus Inc. shares are logging -29.84% during the 52-week period from high price, and 117.03% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.82 and $5.63.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1053325 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Agenus Inc. (AGEN) recorded performance in the market was -9.09%, having the revenues showcasing -15.04% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 665.59M, as it employees total of 328 workers.
Agenus Inc. (AGEN) in the eye of market guru’s
During the last month, 2 analysts gave the Agenus Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 3.96, with a change in the price was noted +0.05. In a similar fashion, Agenus Inc. posted a movement of +1.19% for the period of last 100 days, recording 2,458,365 in trading volumes.
Agenus Inc. (AGEN): Stocks Technical analysis and Trends
Raw Stochastic average of Agenus Inc. in the period of last 50 days is set at 32.96%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 48.13%. In the last 20 days, the company’s Stochastic %K was 37.29% and its Stochastic %D was recorded 27.78%.
If we look into the earlier routines of Agenus Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -9.09%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -9.09%, alongside a downfall of -11.69% for the period of the last 12 months. The shares increased approximately by 1.37% in the 7-day charts and went up by -0.54% in the period of the last 30 days. Common stock shares were lifted by -15.04% during last recorded quarter.